Biopharmaceutical Third-Party Logistics Market Size, Share, Revenue, Trends And Drivers For 2024-2033

The Business Research Company’s Biopharmaceutical Third-Party Logistics Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033

LONDON, GREATER LONDON, UK, August 1, 2024 /EINPresswire.com/ — The biopharmaceutical third-party logistics market has experienced robust growth in recent years, expanding from $131.23 billion in 2023 to $140.68 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to globalization of pharma supply chains, stringent regulatory requirements, rise in biopharmaceuticals, focus on cold chain logistics.

Strong Future Growth Anticipated
The biopharmaceutical third-party logistics market is projected to continue its strong growth, reaching $184.35 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to personalized medicine growth, biologics and biosimilars expansion, supply chain digitalization, regulatory compliance complexity, COVID-19 impact.

Explore Comprehensive Insights Into The Global Biopharmaceutical Third-Party Logistics Market With A Detailed Sample Report:

Growth Driver Of The Biopharmaceutical Third-Party Logistics Market
The launch of innovative biopharmaceutical products is expected to drive the growth of the biopharmaceutical third-party logistics market. Innovative biopharmaceutical products refer to advanced and novel therapeutic substances derived from biological sources, such as monoclonal antibodies or gene therapies. The biopharmaceutical third-party logistics market plays a crucial role in the efficient launch of these products by providing streamlined supply chain solutions, ensuring timely and secure distribution, and supporting the complex logistics involved in bringing these innovative therapies to market.

Make Your Report Purchase Here And Explore The Whole Industry’s Data As Well:

Major Players And Market Trends
Key players in the biopharmaceutical third-party logistics market include McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation.

Technological advancements are a key trend gaining popularity in the biopharmaceutical third-party logistics market. Major companies operating in the biopharmaceutical third-party logistics market are focused on launching new products to strengthen their position and gain a competitive advantage.

Segments:
1) By Supply Chain: Cold Chain, Non-Cold Chain
2) By Service: Transportation, Warehousing And Storage, Other Services
3) By End-User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users

Geographical Insights: North America Leading The Market
North America was the largest region in the biopharmaceutical third party logistics market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Biopharmaceutical Third-Party Logistics Market Definition
Biopharmaceutical third-party logistics refers to a partner or service that helps in the provision of logistics services by external entities to pharmaceutical companies. These companies delegate their transportation needs to third-party providers to minimize costs, and the absence of in-house capabilities is a significant factor driving the expansion of transportation outsourcing.

Biopharmaceutical Third-Party Logistics Global Market Report 2024 from The Business Research Company covers the following information:
•Market size data for the forecast period: Historical and Future
•Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Biopharmaceutical Third-Party Logistics Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on biopharmaceutical third-party logistics market size, biopharmaceutical third-party logistics market drivers and trends, biopharmaceutical third-party logistics market major players, biopharmaceutical third-party logistics competitors’ revenues, biopharmaceutical third-party logistics market positioning, and biopharmaceutical third-party logistics market growth across geographies. The biopharmaceutical third-party logistics market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Biopharmaceutical CMO Global Market Report 2024

Biopharmaceuticals Contract Manufacturing Global Market Report 2024

Lyophilization Services For Biopharmaceuticals Global Market Report 2024

About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn